The Latest Breaking News from FDA

The federal agency says it is proposing a ban on the use of formaldehyde in hair straighteners and smoothers, which have been linked to increased cancer risks.

Histotripsy could cause less harmful side effects compared to radiation and chemotherapy, experts say

The FDA called for treatments for stimulant use disorder. Doctors say current options are limited

FDA officials could ban the products as soon as next spring

The U.S. Food and Drug Administration is considering a ban on certain hair-straightening chemicals that have been used by Black women for years

Communities across the U.S. are confronting a new vaping problem: how to get rid of millions of disposable e-cigarettes that are considered hazardous waste

Over 10,000 food products could be affected when the ban goes into effect

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….

Analyst predicts modest adoption and annual revenue of $220 million by 2030 for Neuralink's N1 brain implant.

The FDA gave Intellia the go-ahead to begin a pivotal study of its gene-editing treatment for a heart disease, but NTLA stock fell.

Tens of thousands die from opioid overdoses in the United States yearly — but medicines like Narcan can reverse overdoses and help reduce the toll.